|
1: Luc G, et al. Adipocytokines and the risk of
coronary heart disease in healthy middle aged men: the PRIME Study.
Int J Obes (Lond). 2010 Jan;34(1):118-26. Epub 2009 Oct 13.
2: Yilmaz Y, et al. Serum levels of omentin, chemerin
and adipsin in patients with biopsy-proven nonalcoholic fatty liver
disease. Scand J Gastroenterol. 2010 Sep
1. [Epub ahead of print]
3: Takeshita A, et al. Elevation of Adipsin, a
Complement Activating Factor, in the Mouse Placenta During Spontaneous
Abortion. J Reprod Dev. 2010 Jun 23. [Epub ahead of print]
4: Ciprandi G, et al. Serum adipsin levels in patients
with seasonal allergic rhinitis: preliminary data. Int
Immunopharmacol. 2009 Nov;9(12):1460-3. Epub 2009 Aug 20.
5: Hietaharju A, et al. Elevated cerebrospinal fluid
adiponectin and adipsin levels in patients withmultiple sclerosis: a
Finnish co-twin study. Eur J Neurol. 2010 Feb;17(2):332-4.
Epub 2009 Jun 15.
6: Fain JN, et al. Release
in vitro of adipsin, vascular cell adhesion molecule 1, angiotensin
1-converting enzyme, and soluble tumor necrosis factor receptor 2 by
human omental adipose tissue as well as by the nonfat cells and
adipocytes. Metabolism. 2007 Nov;56(11):1583-90. |